Sartorius Stedim Biotech (XPAR:DIM) EV-to-Revenue : 8.42 (As of Apr. 25, 2024)

View and export this data going back to 1994. Start your Free Trial

What is Sartorius Stedim Biotech EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sartorius Stedim Biotech's enterprise value is €23,359 Mil. Sartorius Stedim Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €2,776 Mil. Therefore, Sartorius Stedim Biotech's EV-to-Revenue for today is 8.42.

The historical rank and industry rank for Sartorius Stedim Biotech's EV-to-Revenue or its related term are showing as below:

XPAR:DIM' s EV-to-Revenue Range Over the Past 10 Years
Min: 5.71 Med: 9.62 Max: 21.29
Current: 8.42

During the past 13 years, the highest EV-to-Revenue of Sartorius Stedim Biotech was 21.29. The lowest was 5.71. And the median was 9.62.

XPAR:DIM's EV-to-Revenue is ranked worse than
79.27% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: 3.07 vs XPAR:DIM: 8.42

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-25), Sartorius Stedim Biotech's stock price is €203.40. Sartorius Stedim Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €30.14. Therefore, Sartorius Stedim Biotech's PS Ratio for today is 6.75.

Sartorius Stedim Biotech EV-to-Revenue Historical Data

The historical data trend for Sartorius Stedim Biotech's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech EV-to-Revenue Chart

Sartorius Stedim Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

9.54

14.34

15.56

8.30

9.25

Sartorius Stedim Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															8.30	8.11	7.05	8.29	9.25

Competitive Comparison of Sartorius Stedim Biotech's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sartorius Stedim Biotech's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's EV-to-Revenue falls into.

Sartorius Stedim Biotech EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sartorius Stedim Biotech's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	23359.118	/	2775.5
	=	8.42

Sartorius Stedim Biotech's current Enterprise Value is €23,359 Mil.
Sartorius Stedim Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €2,776 Mil.

Sartorius Stedim Biotech (XPAR:DIM) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sartorius Stedim Biotech's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	203.40	/	30.142
	=	6.75

Sartorius Stedim Biotech's share price for today is €203.40.
Sartorius Stedim Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €30.14.

Sartorius Stedim Biotech EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech (XPAR:DIM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (XPAR:DIM) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

SRTOY:USA SDMHF:USA DIM:Mexico DIMp:UK 0RG8:UK 56S1:Germany

Address

Otto-Brenner-Strasse 20, Goettingen, DEU, 37079

Website

https://www.sartorius.com

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.